MiR-130a-3p inhibits the viability, proliferation, invasion, and cell cycle, and promotes apoptosis of nasopharyngeal carcinoma cells by suppressing BACH2 expression. This evidence concerns the gene BACH2 and nasopharyngeal carcinoma.